A vs SPRO · P/E 29, rev $1.88B vs P/E 9.6, rev $48.0M
Agilent Technologies Inc (A) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
A currently screens at market cap $33.70B and trailing P/E 29.2. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the A and SPRO stock pages for the full models.
Not investment advice.